MarketInOut Stock Screener Log In | Sign Up

Kopran Ltd

Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 15:57
Kopran Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
Market Capitalization11,903 mln
Float31.55 mln
Earnings Date11/03/2026

EPS

5.17
Stretched

P / E

48.83
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.37
Borderline

Relative Strength

50 / 100
In line with market

Debt / Equity

0.29
Very low leverage

Business Description

Kopran Limited is a Mumbai-based pharmaceutical company founded in 1958 that makes and sells both raw drug ingredients and finished medicines across India and global markets. The company produces a broad range of products, from everyday tablets and syrups to injectable treatments, covering therapeutic areas such as heart health, diabetes, cancer, respiratory conditions, and infections. Kopran supplies both branded and generic medicines to meet the needs of patients and healthcare providers worldwide.

Key Fundamentals

EPS5.17
P/E48.83
ROE4.84
RPS145
ROIC6.42
ROA2.91
Interest Cover5.40
EBITDA, mln635
EV / EBITDA24.41
EV / EBIT34.83
Revenue, mln7,002
EV / Revenue2.21

Quote Details

Last 252.45
Change 3.15 (1.26%)
Open 249.15
Volume 323,254
Turnover 81,605,472
Average Volume 542,534

Financial Ratios

Pre-Tax Profit Margin5
Current Ratio1.51
Price / Book2.54
Price / Tangible Book2.69
Price / Cash Flow21.47
Price / Free Cash Flow50.80
Debt / Equity0.29
Price / Sales1.91

Financial Strength

Altman Z-Score3.64
Piotroski F-Score 5 / 9
Beneish M-Score-2.37
Price to Intrinsic Value5.65
Price to Graham Number2.50
Shiller PE Ratio29.98

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.39% 27 / 100   
1 Month -11.27% 32 / 100   
2 Months 25.86% 92 / 100   
6 Months 60.27% 94 / 100   
1 Year 54.59% 91 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog